Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised...

por Olagunju, Adeniyi, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez, Adeagbo, Babatunde Ayodeji, Onayade, Adedeji, Bolaji, Oluseye Oladotun, Happi, Christian, Rannard, Steve, Owen, Andrew
Publicado 2021

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

por Fowotade, Adeola, Bamidele, Folasade, Egbetola, Boluwatife, Fagbamigbe, Adeniyi F., Adeagbo, Babatunde A., Adefuye, Bolanle O., Olagunoye, Ajibola, Ojo, Temitope O., Adebiyi, Akindele O., Olagunju, Omobolanle I., Ladipo, Olabode T., Akinloye, Abdulafeez, Onayade, Adedeji, Bolaji, Oluseye O., Rannard, Steve, Happi, Christian, Owen, Andrew, Olagunju, Adeniyi
Publicado 2022